首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1467557

2024-2032 年按癌症類型、產品、技術、最終用戶和地區分類的腫瘤分子診斷市場報告

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球腫瘤分子診斷市場規模達42億美元。

腫瘤分子診斷透過分析癌細胞的生物分子來識別癌細胞的存在。對血液、唾液和腫瘤組織樣本進行多項測試，以檢測和測量 DNA、RNA 和細胞蛋白質中的特定基因序列。腫瘤分子診斷有助於進行快速分析並提供詳細資訊，進一步用於癌症的個人化治療。這些診斷解決方案適用於癌症早期檢測的臨床和照護端 (POC) 測試。它們也用於血庫來識別捐贈的血液樣本中存在的病原體和傳染病。

由於生活方式的改變、老年人口的增加以及吸菸趨勢的增加，癌症盛行率不斷上升，是推動全球腫瘤分子診斷市場成長的主要因素之一。除此之外，對快速且準確診斷的需求不斷成長，以及下一代定序（NGS）技術的進步，正在促進市場的成長。此外，遭受病毒和細菌感染的人數增加以及捐血活動的參與度不斷增加，對全球腫瘤分子診斷的需求產生了積極影響。然而，由於冠狀病毒病（COVID-19）的突然爆發，一些醫療機構正在採取措施，透過減少就診次數來降低癌症患者的大流行風險。此外，由於診斷資源重新用於提供 COVID-19 檢測以及隨之而來的腫瘤學檢測的減少，對癌症患者的定期篩檢有所減少。

本報告回答的關鍵問題：

迄今為止，全球腫瘤分子診斷市場表現如何，未來幾年將如何表現？
COVID-19 對全球腫瘤分子診斷市場有何影響？
主要區域市場有哪些？
根據癌症類型分類的市場是怎麼樣的？
基於產品的市場區隔是什麼？
基於技術的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球腫瘤分子診斷市場的結構如何？
產業競爭程度如何？

乳癌
- 市場走向
- 市場預測
攝護腺癌
- 市場走向
- 市場預測
大腸直腸癌
- 市場走向
- 市場預測
子宮頸癌
- 市場走向
- 市場預測
肝癌
- 市場走向
- 市場預測
肺癌
- 市場走向
- 市場預測
血癌
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 7 章：市場區隔：依產品

儀器
- 市場走向
- 市場預測
試劑
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 8 章：市場區隔：依技術

聚合酶鍊式反應 (PCR)
- 市場走向
- 市場預測
原位雜合技術
- 市場走向
- 市場預測
晶片和微陣列
- 市場走向
- 市場預測
等溫核酸擴增技術（INAAT）
- 市場走向
- 市場預測
質譜
- 市場走向
- 市場預測
DNA 和 NGS 定序
- 市場走向
- 市場預測
轉錄介導的擴增 (TMA)
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 9 章：市場區隔：按最終用戶

醫院和診所
- 市場走向
- 市場預測
參考實驗室
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 10 章：市場區隔：按地區

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Agilent Technologies, Inc.
- Abbott Laboratories
- Bayer AG
- Becton, Dickinson and Company
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Hologic, Inc.
- Qiagen NV
- Siemens Healthcare
- Sysmex Corporation

簡介目錄圖表

Product Code: SR112024A2396

The global oncology molecular diagnostics market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.1 Billion by 2032, exhibiting a growth rate (CAGR) of 13% during 2024-2032.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, product, technology and end-user.

Breakup by Cancer Type:

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Blood Cancer

Others

Breakup by Product:

Instruments

Reagents

Others

Breakup by Technology:

Polymerase Chain Reaction (PCR)

In Situ Hybridization

Chips and Microarrays

Isothermal Nucleic Acid Amplification Technology (INAAT)

Mass Spectrometry

DNA and NGS Sequencing

Transcription Mediated Amplification (TMA)

Others

Breakup by End-User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report:

How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global oncology molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Cancer Type

6.1 Breast Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Prostate Cancer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Colorectal Cancer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cervical Cancer
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Liver Cancer
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Lung Cancer
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Blood Cancer
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast

7 Market Breakup by Product

7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Reagents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Technology

8.1 Polymerase Chain Reaction (PCR)
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 In Situ Hybridization
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Chips and Microarrays
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Mass Spectrometry
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 DNA and NGS Sequencing
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Transcription Mediated Amplification (TMA)
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast

9 Market Breakup by End-User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies, Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Becton, Dickinson and Company
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Danaher Corporation
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 SWOT Analysis
- 15.3.7 Hologic, Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Qiagen N.V.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Siemens Healthcare
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sysmex Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2023
Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2023
Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2023
Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2023
Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Oncology Molecular Diagnostics Market Structure
Table 8: Global: Oncology Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219